Rudy Li
Stock Analyst at Chardan Capital
(0.45)
# 3,952
Out of 4,761 analysts
7
Total ratings
28.57%
Success rate
-13.05%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rudy Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRTA Prothena Corporation | Maintains: Buy | $40 | $15.56 | +157.07% | 3 | Feb 21, 2025 | |
| STOK Stoke Therapeutics | Maintains: Buy | $24 | $8.33 | +188.12% | 2 | Feb 19, 2025 | |
| MNMD Mind Medicine (MindMed) | Initiates: Buy | $20 | $7.63 | +162.12% | 2 | Dec 20, 2024 |
Prothena Corporation
Feb 21, 2025
Maintains: Buy
Price Target: $40
Current: $15.56
Upside: +157.07%
Stoke Therapeutics
Feb 19, 2025
Maintains: Buy
Price Target: $24
Current: $8.33
Upside: +188.12%
Mind Medicine (MindMed)
Dec 20, 2024
Initiates: Buy
Price Target: $20
Current: $7.63
Upside: +162.12%